PharmaEssentia (6446 TW) stock market data APIs
NT$514.0777
8.96(1.7%)
as of October 20, 2025
Try our APIs with
free plan!
PharmaEssentia Financial Data Overview
Price chart is built with
Anychart
PharmaEssentia Corporation, a biopharmaceutical company engages in treatment for human diseases in Taiwan and internationally. Its products include Ropeginterferon alfa-2b that is used for the treatment of chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. The company also develops TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint abs for the treatment of solid tumors; P1101 + anti PD-1 for the treatment of hepatocellular carcinoma; and PEG-GCSF for the treatment of neutropenia. In addition, it focuses on the drug research and development programs in the areas of hematology, infectious disease, and oncology. PharmaEssentia Corporation was founded in 1990 and is headquartered in Taipei, Taiwan.
Prev. Close
514.0777
Open
523.0421
High
523.0421
Low
504.5366
52 wk Range
395.5448-1304.7106
Market Cap
188 616 M
P/E Ratio
46.6179
Shares Outstanding
370 M
Revenue
12 635 M
EPS
2.24
Dividends (Yield)
0.0019
Beta
-0.031
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with PharmaEssentia (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get PharmaEssentia data using free add-ons & libraries
Get PharmaEssentia Fundamental Data
PharmaEssentia Fundamental data includes:
- Net Revenue: 12 635 M
- EBITDA: 3 594 M
- Earnings Per Share: 10
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-12
- EPS/Forecast: 3.51
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
PharmaEssentia News
New
High Growth Tech Stocks in Asia to Watch
As the Asian tech sector navigates a landscape marked by evolving U.S.-China trade dynamics and ongoing economic adjustments, investors are keenly observing how these factors impact growth trajectorie...
High Growth Tech Stocks in Asia with Potential for Expansion
Amidst the backdrop of reignited U.S.-China trade tensions and economic uncertainties, Asian markets are navigating a complex landscape with mixed performances across key indices. In this environment,...
High Growth Tech Stocks In Asia To Watch For Potential Expansion
Amidst cautious sentiment in global markets, with key indices like the Nasdaq Composite and Russell 2000 experiencing declines, Asian tech stocks present a compelling area of interest due to their pot...
Exploring High Growth Tech Stocks in Asia
Amidst global market fluctuations and cautious economic outlooks, Asian tech stocks have been capturing attention with their potential for high growth, driven by innovation and regional economic dynam...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
